MetaCap

Grace Therapeutics Statistics

NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.71-0.01 (-0.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Grace Therapeutics by the numbers

Grace Therapeutics has a market capitalization of $36.0 million based on 21.04M shares outstanding. With trailing EPS of $-1.16, Grace Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.0% below its 50-day average and 36.1% below its 200-day average.

Average daily trading volume is 119.27K shares, or about $203,953 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GRCE valuation vs. peer median

GRCE compared with the median of 8 peer companies
MetricGRCEPeer medianDifference
Market cap$35.97M$35.79M+1%
Avg. volume119.27K333.40K-64%

Peer median across 8 companies: PLRX, SDEV, CNTB, CUE, DWTX, VERU, ATNM, HYFT.

Valuation

Price and trading

Previous close
1.72
Open
1.71
Day range
1.68 – 1.82
52-week range
1.64 – 5.18
52-week change
-46.39%
Beta
—
Volume
153.91K

Dividends and events

Annual dividend
None
Next earnings date
Jun 20, 2025

Additional statistics

Market Cap
35.97M
Forward Pe
-4.03
Eps
-1.16
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.18
Week52 Low
1.64
Avg Volume
119.27K
Shares Outstanding
21.04M
Ma50
1.97
Ma200
2.68
Earnings Date
Jun 20, 2025
Pct From52w High
-66.99%
Pct From52w Low
4.27%

Related